Smith Salley & Associates boosted its stake in shares of Aflac Inc. (NYSE:AFL) by 2.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,540 shares of the company’s stock after buying an additional 70 shares during the period. Smith Salley & Associates’ holdings in Aflac were worth $255,000 as of its most recent filing with the SEC.
Several other large investors have also recently added to or reduced their stakes in AFL. JNBA Financial Advisors purchased a new stake in Aflac during the second quarter valued at $24,130,000. Orbis Allan Gray Ltd purchased a new stake in Aflac during the first quarter valued at $25,991,000. Dividend Assets Capital LLC increased its stake in Aflac by 25.1% in the second quarter. Dividend Assets Capital LLC now owns 536,795 shares of the company’s stock valued at $38,735,000 after buying an additional 107,795 shares during the period. Legal & General Group Plc increased its stake in Aflac by 0.5% in the first quarter. Legal & General Group Plc now owns 1,912,237 shares of the company’s stock valued at $120,747,000 after buying an additional 9,569 shares during the period. Finally, RS Investment Management Co. LLC increased its stake in Aflac by 20.6% in the second quarter. RS Investment Management Co. LLC now owns 767,450 shares of the company’s stock valued at $55,379,000 after buying an additional 130,920 shares during the period. 62.89% of the stock is currently owned by institutional investors.
Shares of Aflac Inc. (NYSE:AFL) traded up 0.98% during mid-day trading on Friday, reaching $71.30. The company’s stock had a trading volume of 430,840 shares. The company has a market cap of $29.20 billion, a P/E ratio of 11.73 and a beta of 1.33. The company has a 50-day moving average of $72.48 and a 200-day moving average of $70.39. Aflac Inc. has a 12 month low of $54.57 and a 12 month high of $74.50.
Aflac (NYSE:AFL) last posted its quarterly earnings results on Thursday, July 28th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.68 by $0.03. Aflac had a net margin of 12.12% and a return on equity of 14.30%. The business earned $5.44 billion during the quarter, compared to analyst estimates of $5.45 billion. During the same period in the prior year, the business posted $1.50 earnings per share. The company’s revenue was up 2.8% on a year-over-year basis. Equities research analysts forecast that Aflac Inc. will post $6.85 earnings per share for the current fiscal year.
Several equities research analysts recently weighed in on AFL shares. FBR & Co reissued a “hold” rating on shares of Aflac in a report on Friday, July 29th. Credit Suisse Group AG assumed coverage on Aflac in a report on Friday, October 7th. They set an “underperform” rating and a $75.00 price objective on the stock. Wells Fargo & Co. assumed coverage on Aflac in a report on Friday, September 23rd. They set a “market perform” rating on the stock. JPMorgan Chase & Co. reaffirmed a “hold” rating on shares of Aflac in a report on Wednesday, July 6th. Finally, Vetr raised Aflac from a “hold” rating to a “buy” rating and set a $70.50 target price on the stock in a report on Monday, June 27th. Three research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $69.88.
In other news, Director Barbara K. Rimer sold 3,650 shares of the stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $71.74, for a total transaction of $261,851.00. Following the completion of the sale, the director now directly owns 15,910 shares in the company, valued at $1,141,383.40. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Teresa L. White sold 35,734 shares of the stock in a transaction dated Thursday, September 1st. The stock was sold at an average price of $74.28, for a total transaction of $2,654,321.52. Following the sale, the insider now owns 29,633 shares of the company’s stock, valued at $2,201,139.24. The disclosure for this sale can be found here. Company insiders own 3.90% of the company’s stock.
Aflac Company Profile
Aflac Incorporated is a business holding company. The Company engaged in is supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). Aflac’s insurance business consists of two segments: Aflac Japan and Aflac U.S.
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Inc. (NYSE:AFL).
Receive News & Ratings for Aflac Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac Inc. and related companies with MarketBeat.com's FREE daily email newsletter.